home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

High-Resolution Whole-Genome Association Study Of Parkinson Disease

  October, 19 2005 10:35
your information resource in human molecular genetics
High-Resolution Whole-Genome Association Study Of Parkinson Disease

Demetrius M. Maraganore (1), Mariza de Andrade (2), Timothy G. Lesnick (2), Kari J. Strain (2), Matthew J. Farrer (3), Walter A. Rocca (1,2), P. V. Krishna Pant (4), Kelly A. Frazer (4), David R. Cox (4), and Dennis G. Ballinger (4)

Author Affiliations:
Departments of (1) Neurology and (2) Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN; (3) Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL; and (4) Perlegen Sciences, Mountain View, CA

The authors performed a two-tiered, whole-genome association study of Parkinson disease (PD). For tier 1, they individually genotyped 198,345 uniformly spaced and informative single-nucleotide polymorphisms (SNPs) in 443 sibling pairs discordant for PD. For tier 2a, they individually genotyped 1,793 PD-associated SNPs and 300 genomic control SNPs in 332 matched case unrelated control pairs.

They identified 11 SNPs that were associated with PD in both tier 1 and tier 2 samples and had the same direction of effectIn analysis of the combined tier 1 and tier 2b data, the two SNPs with the lowest P values tagged the PARK10 late-onset PD susceptibility locus.

Independent replication across populations will clarify the role of the genomic loci tagged by these SNPs in conferring PD susceptibility.

Abstract available online.

(C) American Journal of Human Genetics.

Posted by: Tressie Dalaya

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.